JACC This Week
730 episodes — Page 10 of 15
Semaglutide and NTproBNP in Obesity-Related HFpEF: Insights from STEP-HFpEF Program
Audio Commentary by Dr. Valentin Fuster, Emeritus Editor in Chief
Intravenous Iron Repletion for Patients with Heart Failure and Iron Deficiency: JACC State-of-the-Art Review
Commentary by Dr. Valentin Fuster
Addressing the Global Burden of Cardiovascular Disease in Women: JACC State-of-the-Art Review
Commentary by Dr. Valentin Fuster
Randomized Trial of a Vascular Care Team vs Education for Patients with Peripheral Artery Disease
Commentary by Dr. Valentin Fuster
Timing of P2Y12-inhibitor Administration in Patients with STEMI Undergoing Primary PCI
Commentary by Dr. Valentin Fuster
JACC - June 25, 2024 Issue Summary
Audio Summary of the June 25 issue of JACC, by Dr. Valentin Fuster
Ten-Year Mortality after ST-Segment Elevation Myocardial Infarction Compared to the General Population
Commentary by Dr. Valentin Fuster
Association of Autoimmune Diseases with Coronary Atherosclerosis Severity and Ischemic Events
Commentary by Dr. Valentin Fuster
2024 ACC/AHA/AACVPR/APMA/ ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Commentary by Dr. Valentin Fuster
JACC - June 18, 2024 Issue Summary
Audio Summary of the June 18 issue of JACC, by Dr. Valentin Fuster
Artificial Intelligence in Cardiovascular Care — Part 2: Applications: JACC Review Topic of the Week
Commentary by Dr. Valentin Fuster
Mineralocorticoid Receptor Antagonists in Patients with Heart Failure and Impaired Renal Function
Commentary by Dr. Valentin Fuster
SGLT2 Inhibitor Therapy in Patients with Transthyretin Amyloid Cardiomyopathy
Commentary by Dr. Valentin Fuster
Geographical Mapping of Gender Disparities in Authorship of Cardiovascular Literature
Commentary by Dr. Valentin Fuster
Artificial Intelligence for Cardiovascular Care — Part 1: Advances : JACC Review Topic of the Week
Commentary by Dr. Valentin Fuster
Impact of Social Determinants of Health on Predictive Models for Outcomes after Congenital Heart Surgery
Commentary by Dr. Valentin Fuster
Pollution and Cardiovascular Disease, Part 1: Environmentally Not So Friendly:Global Warming, Air Pollution,and Wildfires: JACC Focus Seminar
Commentary by Dr. Valentin Fuster
JACC - June 11, 2024 Issue Summary
Audio Summary of the June 11 issue of JACC, by Dr. Valentin Fuster
Randomized Trial of Remote Assessment of Patients after an Acute Coronary Syndrome
Commentary by Dr. Valentin Fuster
Global, and Regional Cardiovascular Mortality Attributable to Non-optimal Temperatures over Time
Commentary by Dr. Valentin Fuster
Pollution and Cardiovascular Disease, Part 2: Water, Soil, Noise and Light Pollution: JACC Focus Seminar
Commentary by Dr. Valentin Fuster
Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction
Commentary by Dr. Valentin Fuster
Excess Apolipoprotein B and Cardiovascular Risk in Women and Men
Commentary by Dr. Valentin Fuster
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
Commentary by Dr. Valentin Fuster
Transcatheter Covered Stent Exclusion of Superior Sinus Venosus Defects
Commentary by Dr. Valentin Fuster
Coronary Atherosclerotic Plaque Activity and Myocardial Infarction: A vessel-level analysis of the PRE18FFIR study
Commentary by Dr. Valentin Fuster
Reperfusion Injury in Patients with Acute Myocardial Infarction: JACC: Scientific Statement
Commentary by Dr. Valentin Fuster
JACC - June 4, 2024 Issue Summary
Audio Summary of the June 4 issue of JACC, by Dr. Valentin Fuster
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI
Commentary by Dr. Valentin Fuster
Effects of Sacubitril/Valsartan in Patients with Heart Failure Across the Spectrum of Kidney Risk
Commentary by Dr. Valentin Fuster
Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review
Commentary by Dr. Valentin Fuster
Clinical Outcome of Different Microvascular Injury Patterns after STEMI - A Multicenter Cardiac MRI Study
Commentary by Dr. Valentin Fuster
JACC - May 28, 2024 Issue Summary
Audio Summary of the May 28 issue of JACC, by Dr. Valentin Fuster
Clinical Risk Assessment Across the Lifespan in Patients with Congenital Heart Disease: JACC Scientific Statement
Commentary by Dr. Valentin Fuster
A Technology-Assisted Web Application for Consumer Access to a Non-prescription Statin Medication
Commentary by Dr. Valentin Fuster
Personalized Intervention Based on Early Detection of Atherosclerosis: JACC State-of-the-Art Review
Commentary by Dr. Valentin Fuster
Prognostic Value of MRR After Primary PCI: a Pooled Analysis of Individual Patient Data
Commentary by Dr. Valentin Fuster
Safety and Efficacy of Metabolic Modulation with Ninerafaxstat in Nonobstructive Hypertrophic Cardiomyopathy: Phase 2 Study
Commentary by Dr. Valentin Fuster
JACC - May 21, 2024 Issue Summary
Audio Summary of the May 21 issue of JACC, by Dr. Valentin Fuster
Targeting the Substrate for Atrial Fibrillation: JACC Review Topic of the Week
Commentary by Dr. Valentin Fuster
Small Left Ventricle is Associated with an Increased Cardiovascular Risk in Patients with Atrial Fibrillation
Commentary by Dr. Valentin Fuster
Dapagliflozin and Days of Full Health Lost in the DAPA-HF Trial
Commentary by Dr. Valentin Fuster
An Inclisiran First Strategy vs Usual Care in Patients with Atherosclerotic Cardiovascular Disease
Commentary by Dr. Valentin Fuster
Case Volumes and Outcomes among Early Career Interventional Cardiologists in the United States
Commentary by Dr. Valentin Fuster
Managing Implanted Cardiac Electronic Devices in Patients with Severe Tricuspid Regurgitation: JACC State-of-the-Art Review
Commentary by Dr. Valentin Fuster
Ventricular Septal Rupture After Myocardial Infarction: JACC Focus Seminar 3/5
Commentary by Dr. Valentin Fuster
JACC - May 14, 2024 Issue Summary
Audio Summary of the May 14 issue of JACC, by Dr. Valentin Fuster
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Cardiomyopathies
Commentary by Dr. Valentin Fuster
Long-term Cardiovascular Risk Associated with Treatment of Attention-Deficit/Hyperactivity Disorder in Adults
Commentary by Dr. Valentin Fuster
Prevalence of Cardiovascular Disease and Risk Factors among National Football League Alumni and Family Members
Commentary by Dr. Valentin Fuster